We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
+$9.85M
Cap. Flow
+$95.1M
Cap. Flow %
9.1%
Top 10 Hldgs %
50%
Holding
874
New
223
Increased
214
Reduced
73
Closed
220

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$54.9M
2
IMCR icon
Immunocore
IMCR
+$48.2M
3
ARKK icon
ARK Innovation ETF
ARKK
+$41.6M
4
TWTR
Twitter, Inc.
TWTR
+$36.7M
5
RNAM
Avidity Biosciences
RNAM
+$29.2M

Top Sells

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$23.6M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$19M
3
RBAC
RedBall Acquisition Corp.
RBAC
+$12.5M
4
SMFG icon
Sumitomo Mitsui Financial
SMFG
+$12.1M
5
STOK icon
Stoke Therapeutics
STOK
+$11.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Financials 8.03%
3 Materials 6.97%
4 Technology 3.58%
5 Industrials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHUAW
326
DELISTED
SHUAA Partners Acquisition Corp I Warrant
SHUAW
$21K ﹤0.01%
258,340
– –
SGHLW
327
DELISTED
Signal Hill Acquisition Corp. Warrant
SGHLW
$21K ﹤0.01%
185,366
+900
+0.5% +$131
IBER.WS
328
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$21K ﹤0.01%
250,974
+32,691
+15% +$3.5K
MIST icon
329
Milestone Pharmaceuticals
MIST
$158M
$20K ﹤0.01%
+14,000
New +$106K
SKGRW
330
DELISTED
SK Growth Opportunities Corporation Warrant
SKGRW
$20K ﹤0.01%
+132,000
New +$25.6K
IMAQR
331
DELISTED
International Media Acquisition Corp. Rights
IMAQR
$20K ﹤0.01%
200,000
+87,199
+77% +$5.49K
VHAQ.WS
332
DELISTED
Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
$20K ﹤0.01%
219,200
-45,800
-17% -$3.23K
EOCW.WS
333
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$20K ﹤0.01%
+126,829
New +$31.6K
HORIW
334
DELISTED
Emerging Markets Horizon Corp. Warrants
HORIW
$20K ﹤0.01%
196,471
-4,000
-2% -$367
ARGUW
335
DELISTED
Argus Capital Corp. Warrant
ARGUW
$20K ﹤0.01%
133,046
– –
JUN.WS
336
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$20K ﹤0.01%
150,773
-38,177
-20% -$7.29K
RMGCW
337
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$19K ﹤0.01%
160,942
+41,418
+35% +$4.25K
JAQCW
338
DELISTED
Jupiter Acquisition Corporation Warrants
JAQCW
$19K ﹤0.01%
+174,142
New +$21.8K
ARBGW
339
DELISTED
Aequi Acquisition Corp warrants
ARBGW
$19K ﹤0.01%
473,953
+5,590
+1% +$419
ADALW
340
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
$19K ﹤0.01%
149,500
-63,685
-30% -$11.5K
FPAC.WS
341
DELISTED
Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
FPAC.WS
$19K ﹤0.01%
+84,333
New +$27.3K
GRRRW
342
Gorilla Technology Group Warrant
GRRRW
$1.79M
$18K ﹤0.01%
+49,553
New +$17.3K
PIIIW icon
343
P3 Health Partners Inc Warrant
PIIIW
$191K
$18K ﹤0.01%
25,000
– –
UHGWW
344
DELISTED
United Homes Group Warrant
UHGWW
$18K ﹤0.01%
73,852
+31,902
+76% +$5.22K
BLEUW
345
DELISTED
bleuacacia ltd Warrants
BLEUW
$18K ﹤0.01%
230,691
+600
+0.3% +$66
VSACW
346
DELISTED
Vision Sensing Acquisition Corp. Warrants
VSACW
$18K ﹤0.01%
365,571
+71,931
+24% +$5.34K
EACPW
347
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$18K ﹤0.01%
350,270
+148,090
+73% +$14.2K
ARTEW
348
DELISTED
Artemis Strategic Investment Corporation Warrant
ARTEW
$18K ﹤0.01%
178,249
+66,350
+59% +$6.98K
PIAI.WS
349
DELISTED
Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PIAI.WS
$18K ﹤0.01%
299,960
-57,662
-16% -$2.84K
GXIIW
350
DELISTED
GX Acquisition Corp. II Warrant
GXIIW
$18K ﹤0.01%
184,616
+77,201
+72% +$6.65K
12 13
14
15 16

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2022 Portfolio in Review

As of Q3 2022, Cowen and Company held 874 positions worth $1.05B, up 0.95% from $1.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cowen and Company deployed $95.1M of net new capital in Q3 2022, opening 223 new positions and adding to 214 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $23.6M trimmed.

  • Cowen and Company's largest Q3 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.
  • Cowen and Company added most to ARK Innovation ETF in Q3 2022, an estimated $41.6M increase.
  • Cowen and Company's biggest Q3 2022 reduction was Relmada Therapeutics, cutting an estimated $23.6M.
  • Cowen and Company fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $19M.
  • Cowen and Company's ten largest holdings make up 50% of its $1.05B portfolio in Q3 2022.
  • Cowen and Company opened 223 new positions and closed 220 in Q3 2022.
  • Cowen and Company's portfolio value rose 0.95% quarter-over-quarter to $1.05B.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.